Analyte | Nominal value (μg/mL) | Stability conditions | |||
---|---|---|---|---|---|
Human plasma (analyte concentration (%)) | Mobile phase | ||||
RT (4 h) | 4 °C (48 h) | −20 °C (15 days) | 4 °C (24 h) | ||
Perindopril | 1.5 | 97.25 | 102.4 | 96.15 | 98.45 |
7 | 100.06 | 98.2 | 95.29 | 99.1 | |
25 | 98.33 | 99.65 | 96.72 | 99.58 | |
Indapamide | 0.45 | 101.6 | 103.08 | 97.26 | 102.5 |
2.5 | 97.05 | 98.15 | 93 | 100.25 | |
12 | 98.3 | 100.2 | 95.52 | 97 |